{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:11Z","timestamp":1786118771168,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/mcg.0b013e31804d2399","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T01:45:27Z","timestamp":1181785527000},"page":"546-547","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Intermittent Reflux Symptoms: One Size Does not Fit All"],"prefix":"10.1097","volume":"41","author":[{"given":"Kenneth R.","family":"DeVault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210305","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","article-title":"Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease","volume":"100","author":"DeVault","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R2-2-20210305","first-page":"451","article-title":"Long-term prescribing of proton pump inhibitors in general practice","volume":"49","author":"Hungin","year":"1999","journal-title":"Br J Gen Pract"},{"key":"R3-2-20210305","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"R5-2-20210305","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365528509089680","article-title":"Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial","volume":"20","author":"Grove","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"R6-2-20210305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365528909093066","article-title":"Symptomatic effect of low-dose antacid regimen in reflux oesophagitis","volume":"24","author":"Weberg","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"R7-2-20210305","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1365-2036.1999.00654.x","article-title":"Onset of action during on-demand treatment with Maalox suspension or low-dose ranitidine for heartburn","volume":"13","author":"Faaij","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-2-20210305","first-page":"A350","article-title":"Time to onset of action of sodium alginate, rantidine, omeprazole and water based on oesophageal pH [Abstract]","volume":"116","author":"Washington","year":"1999","journal-title":"Gastroenterology"},{"key":"R9-2-20210305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0149-2918(97)80074-4","article-title":"On-demand therapy in gastroesophageal reflux disease: a comparison of the early effects of single doses of fast-dissolving famotidine wafers and ranitidine tablets","volume":"19","author":"Johannessen","year":"1997","journal-title":"Clin Ther"},{"key":"R10-2-20210305","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2036.1998.00384.x","article-title":"On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo","volume":"12","author":"Galmiche","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-2-20210305","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2036.1999.00575.x","article-title":"On demand therapy for reflux oesophagitis\u2014a prospective study of symptoms, patient satisfaction and quality of life","volume":"13","author":"Wilhelmsen","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-2-20210305","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","article-title":"Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole: a five-way crossover trial","volume":"98","author":"Miner","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R13-2-20210305","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2036.2004.02079.x","article-title":"Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study","volume":"20","author":"Katz","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"R14-2-20210305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.2005.02709.x","article-title":"Review article: immediate-release proton-pump inhibitory therapy\u2014potential advantages","volume":"22","author":"Howden","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-2-20210305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000091298","article-title":"Acid suppression therapy: where do we go from here?","volume":"24","author":"Scarpignato","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R16-2-20210305","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/bmj.318.7182.502","article-title":"Symptomatic gastroesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine","volume":"318","author":"Bardhan","year":"1999","journal-title":"BMJ"},{"key":"R17-2-20210305","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"key":"R18-2-20210305","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"key":"R19-2-20210305","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004836-200707000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:43:44Z","timestamp":1786034624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-200707000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31804d2399","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}